AmerisourceBergen (NYSE:ABC) EVP Robert P. Mauch sold 1,000 shares of the business’s stock in a transaction on Tuesday, April 17th. The shares were sold at an average price of $90.00, for a total value of $90,000.00. Following the sale, the executive vice president now owns 13,123 shares in the company, valued at $1,181,070. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Shares of ABC traded up $1.71 during midday trading on Thursday, reaching $92.75. The stock had a trading volume of 2,060,619 shares, compared to its average volume of 2,006,254. AmerisourceBergen has a 12-month low of $71.90 and a 12-month high of $106.27. The company has a current ratio of 0.95, a quick ratio of 0.50 and a debt-to-equity ratio of 1.61. The stock has a market capitalization of $19,998.67, a P/E ratio of 15.77, a PEG ratio of 1.37 and a beta of 1.06.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.35 by $0.20. The firm had revenue of $40.47 billion during the quarter, compared to analysts’ expectations of $40.42 billion. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.36 EPS. equities research analysts predict that AmerisourceBergen will post 6.54 EPS for the current year.
A number of equities analysts have weighed in on the company. Zacks Investment Research lowered AmerisourceBergen from a “buy” rating to a “hold” rating in a research note on Tuesday, March 20th. Argus upped their target price on AmerisourceBergen from $93.96 to $115.00 and gave the stock a “buy” rating in a research note on Monday, March 5th. Bank of America assumed coverage on AmerisourceBergen in a research note on Tuesday, February 27th. They issued a “buy” rating and a $111.00 target price on the stock. Jefferies Group set a $95.00 target price on AmerisourceBergen and gave the stock a “hold” rating in a research note on Wednesday, February 7th. Finally, Royal Bank of Canada restated a “hold” rating and issued a $102.00 target price on shares of AmerisourceBergen in a research note on Wednesday, February 7th. Two research analysts have rated the stock with a sell rating, six have given a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $102.72.
COPYRIGHT VIOLATION NOTICE: This article was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://stocknewstimes.com/2018/04/19/amerisourcebergen-abc-evp-robert-p-mauch-sells-1000-shares-of-stock.html.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.